1257779
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 13, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Boston, MA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)